XML 48 R32.htm IDEA: XBRL DOCUMENT

Revenue Recognition Segment revenue by major payor (Tables)

3 Months Ended

Mar. 31, 2018

Revenues by major payor [Abstract]

Schedule of Revenue Sources, Health Care Organization [Table Text Block]

The following table summarizes the Company's segment revenues by primary payor source:



	For the three months ended
	March 31, 2018												March 31, 2017⁽¹⁾
	U.S. dialysis and related lab services				Other - Ancillary services and strategic initiatives				Consolidated				U.S. dialysis and related lab services				Other - Ancillary services and strategic initiatives				Consolidated
Patient service revenues:
Medicare and Medicare Advantage	$	1,485,192			$	—			$	1,485,192			$	1,272,595			$	—			$	1,272,595
Medicaid and Managed Medicaid	157,496				—				157,496				144,585				—				144,585
Other government	107,119				82,537				189,656				91,993				47,761				139,754
Commercial	782,979				19,718				802,697				756,710				13,883				770,593
Other revenues:
Medicare and Medicare Advantage	—				142,758				142,758				—				225,203				225,203
Medicaid and Managed Medicaid	—				15,791				15,791				—				18,595				18,595
Commercial	—				40,420				40,420				—				25,207				25,207
Other⁽²⁾	5,114				38,941				44,055				5,311				47,576				52,887
Eliminations of intersegment revenues	(18,422		)		(10,199		)		(28,621		)		(11,799		)		(6,369		)		(18,168		)
Total	$	2,519,478			$	329,966			$	2,849,444			$	2,259,395			$	371,856			$	2,631,251


(1)	As noted above, prior period amounts have not been adjusted under the cumulative effect method. The Company's dialysis and related lab services revenues for the three months ended March 31, 2017 has been presented net of the provision for uncollectible accounts of $107,058 in this table to conform to the current period presentation.


(2)	Other consists of management fees and revenue from the Company's ancillary services and strategic initiatives.